CTA1R9K-X-DD (Toleranzia)

N/A

Report date: 2025/01/26 17:14:51

Base Information

Drug NameCTA1R9K-X-DD (Toleranzia)
Drug Alias NameCTA1R7K-COL-DD (Toleranzia)CTA1R7K-COL-DD (MIVAC Development)RA Re-Tolerogen
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMIVAC Development
China Registration ClassN/A

Develop Information

Active CompaniesToleranzia AB
Inactive CompaniesMIVAC Development
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A